The influence of precursor depletion and dose regimens on resistance to erythropoiesis-stimulating agents: insights from simulations with instantaneous dose-adaptation algorithm
出版年份 2023 全文链接
标题
The influence of precursor depletion and dose regimens on resistance to erythropoiesis-stimulating agents: insights from simulations with instantaneous dose-adaptation algorithm
作者
关键词
-
出版物
JOURNAL OF PHARMACEUTICAL SCIENCES
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-11-01
DOI
10.1016/j.xphs.2023.10.037
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient
- (2022) David A. Goodkin et al. AMERICAN JOURNAL OF NEPHROLOGY
- Fate determination role of erythropoietin and romiplostim in the lineage commitment of hematopoietic progenitors
- (2022) Xiaoqing Fan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A Novel Combination Therapy of Erythropoietin and Thrombopoietin to Treat Erythropoietin-Resistance anemia
- (2022) Huixi Zou et al. PHARMACEUTICAL RESEARCH
- A Full Target-Mediated Drug Disposition (TMDD) Model to Explain the Changes in Recombinant Human Erythropoietin (rhEpo) Pharmacokinetics in Patients with Different Bone Marrow Integrity Following Hematopoietic Transplantation
- (2022) Nan Wu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Chronic kidney disease
- (2021) Kamyar Kalantar-Zadeh et al. LANCET
- Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease
- (2020) Roberto Minutolo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Impact of serum hepcidin and inflammatory markers on resistance to erythropoiesis-stimulating therapy in haemodialysis patients
- (2019) D. A. El Sewefy et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis
- (2019) Yusuke Sakaguchi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: a population-based study
- (2019) Ingrasciotta Ylenia et al. BMC Nephrology
- Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018
- (2018) Steven Fishbane et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure)
- (2018) Peter van der Meer et al. Circulation-Heart Failure
- OUP accepted manuscript
- (2018) NEPHROLOGY DIALYSIS TRANSPLANTATION
- Iron deficiency across chronic kidney disease stages: Is there a reverse gender pattern?
- (2018) Mabel Aoun et al. PLoS One
- CKD prevention: Perspectives in Hong Kong
- (2018) Sydney CW Tang NEPHROLOGY
- Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients
- (2016) Jiacong Luo et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The greatly misunderstood erythropoietin resistance index and the case for a new responsiveness measure
- (2016) Yossi Chait et al. Hemodialysis International
- Effects of Secondary Hyperparathyroidism Treatment on Improvement in Anemia: Results from the MBD-5D Study
- (2016) Motoko Tanaka et al. PLoS One
- Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease
- (2015) Natalie A. Bello et al. EUROPEAN JOURNAL OF HEART FAILURE
- Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients
- (2015) Myoung Nam Bae et al. PLoS One
- Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E
- (2014) J. Li et al. BLOOD
- Clinical Pharmacokinetics and Pharmacodynamics of Erythropoiesis-Stimulating Agents
- (2013) Sameer Doshi et al. CLINICAL PHARMACOKINETICS
- Peginesatide for Anemia in Patients with Chronic Kidney Disease Not Receiving Dialysis
- (2013) Iain C. Macdougall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
- (2013) Marit M Suttorp et al. BMC Nephrology
- Hepcidin and iron homeostasis
- (2012) Tomas Ganz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Between subjects variability in haemoglobin and dose are not associated with the erythropoiesis-stimulating agent used to treat anaemia in dialysis: a meta-analysis
- (2012) Juan José Pérez-Ruixo et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Methods of solving rapid binding target-mediated drug disposition model for two drugs competing for the same receptor
- (2012) Xiaoyu Yan et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Erythropoietin-Induced Erythroid Precursor Pool Depletion Causes Erythropoietin Hyporesponsiveness
- (2012) Xiaoyu Yan et al. PHARMACEUTICAL RESEARCH
- Shortened Red Blood Cell Lifespan Is Related to the Dose of Erythropoiesis-Stimulating Agents Requirement in Patients on Hemodialysis
- (2012) Yasuyuki Sato et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Time-dependent clearance and hematological pharmacodynamics upon erythropoietin multiple dosing in rats
- (2010) Sihem Ait-Oudhia et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact
- (2010) Zoltán Kiss et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes
- (2010) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hyporesponsiveness to Erythropoietin: Causes and Management
- (2009) James Elliott et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Erythropoiesis Stimulatory Agent- Resistant Anemia in Dialysis Patients: Review of Causes and Management
- (2009) Mehmet Kanbay et al. BLOOD PURIFICATION
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Investigation of the effects of altered receptor binding activity on the clearance of erythropoiesis-stimulating proteins: Nonerythropoietin receptor-mediated pathways may play a major role
- (2008) Balaji Agoram et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
- (2008) Lynda A. Szczech et al. KIDNEY INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started